Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Victor J. Navarro"'
Autor:
Hans L. Tillmann, Herbert L. Bonkovsky, David E. Kleiner, Jose Serrano, Leonard B. Seeff, Jay H. Hoofnagle, Ikhlas A. Khan, Jawad Ahmad, Elizabeth J. Phillips, Francisco Durazo, Robert J. Fontana, Victor J. Navarro, Christopher Koh, Jiezhun Gu, Huiman X. Barnhart, Andrew Stolz, Don C. Rockey, Yi-Ju Li, Raj Vuppalanchi
Publikováno v:
Clin Gastroenterol Hepatol
BACKGROUND: Garcinia cambogia, either alone or with green tea, is commonly promoted for weight loss. Sporadic cases of liver failure from G. cambogia have been reported, but its role in liver injury is controversial. METHODS: Among 1418 patients enro
Autor:
Victor J Navarro, Steven H Belle, Massimo D'Amato, Nezam Afdhal, Elizabeth M Brunt, Michael W Fried, K Rajender Reddy, Abdus S Wahed, Stephen Harrison, Silymarin in NASH and C Hepatitis (SyNCH) Study Group
Publikováno v:
PLoS ONE, Vol 14, Iss 10, p e0223915 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0221683.].
Externí odkaz:
https://doaj.org/article/3ee6c10a9c4f42ffb222f81349bdbd79
Autor:
Victor J Navarro, Steven H Belle, Massimo D'Amato, Nezam Adfhal, Elizabeth M Brunt, Michael W Fried, K Rajender Reddy, Abdus S Wahed, Stephen Harrison, Silymarin in NASH and C Hepatitis (SyNCH) Study Group
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0221683 (2019)
The botanical product silymarin, an extract of milk thistle, is commonly used by patients to treat chronic liver disease and may be a treatment for NASH due to its antioxidant properties. We aimed to assess the safety and efficacy of higher than cust
Externí odkaz:
https://doaj.org/article/b4c82fe0862543efb3cbc0a5e4b86389
Publikováno v:
J Clin Exp Hepatol
Autor:
Manisha Verma, Andrzej S. Kosinski, Jan C. DeNofrio, Marie Bakitas, Michael L. Volk, Tamar H. Taddei, Kavitha Ramchandran, Victor J. Navarro
Publikováno v:
Hepatology Communications. 6:920-930
Palliative care (PC) benefits patients with serious illness including end-stage liver disease (ESLD). As part of a cluster randomized trial, hepatologists were trained to deliver primary palliative care to patients with ESLD using an online course, P
Autor:
Herbert L. Bonkovsky, Jose Serrano, Ikhlas A. Khan, Raj Vuppalanchi, Hans L. Tillmann, Jawad Ahmad, Christopher Koh, Francisco Durazo, Robert J. Fontana, Andrew Stolz, Huiman X. Barnhart, David E. Kleiner, Don C. Rockey, Yi-Ju Li, Elizabeth J. Phillips, Jiezhun Gu, Leonard B. Seeff, Jay H. Hoofnagle, Victor J. Navarro
Publikováno v:
Hepatology
BACKGROUND AND AIMS Herbal supplements, and particularly multi-ingredient products, have become increasingly common causes of acute liver injury. Green tea is a frequent component in implicated products, but its role in liver injury is controversial.
Autor:
Rohit Nathan, Victor J. Navarro, Eyob Feyssa, Naemat Sandhu, James Walter, Radi Zaki, Nikolaos Chandolias
Publikováno v:
GastroHep. 2:327-335
Autor:
Alex Y. Chang, Simona Rossi, Tamara Noonan, Conrado M Fernandez-Rodriguez, James M. Ford, E. Cooney, Luis Colombato, Paul J. Martin, Joseph K. Lim, Atif Zaman, Victor J. Navarro, Mete Korkmaz
Publikováno v:
Journal of Clinical and Translational Hepatology
Background and Aims: In the REALM (Randomized, Observational Study of Entecavir to Assess Long-Term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV Infection) study, 12,378 patients with chronic hepatitis B vi
Autor:
Naemat Sandhu, Victor J. Navarro
Publikováno v:
Hepatology Communications, Vol 4, Iss 5, Pp 631-645 (2020)
Hepatology Communications
Hepatology Communications
Although drug‐induced liver injury (DILI) is a rare clinical event, it carries significant morbidity and mortality, leaving it as the leading cause of acute liver failure in the United States. It is one of the most challenging diagnoses encountered
Autor:
Marwan Ghabril, Ikhlas A. Khan, Jon G. Jonasson, Victor J. Navarro, Bharathi Avula, Einar Bjornsson, Helgi Björnsson, Paul H. Hayashi
Publikováno v:
Liver International. 40:825-829
Background & aims Ashwagandha (Withania somnifera) is widely used in Indian Ayurvedic medicine. Several dietary supplements containing ashwagandha are marketed in the US and Europe, but only one case of drug-induced liver injury (DILI) due to ashwaga